Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Itonis Pharmaceuticals has announce that, with the finalization of its new packaging design and product labeling, it has given the go ahead to Oasis Health Products to produce 16,000 units of its Emesyl homeopathic product.
Subscribe to our email newsletter
Itonis has pre-paid necessary funds to Oasis to commence the inaugural production run.
"The Company is excited that we have finally developed Emesyl to start production. We are in good hands with Oasis Health Products and we cannot wait for the first Emesyl that we can proudly market and place on store shelves," says Mark Cheung, the Company’s CEO.
Itonis Pharmaceuticals, a division of Itonis, Inc., is headed by Charles Hensley, Ph.D., and its mission is to create and market over-the-counter and prescription homeopathic products that better people’s lives. Dr. Hensley is a pioneer in the development and marketing of safe and effective therapeutic nutraceutical and homeopathic preparations.
He was a founder of the company that launched the Zicam Cold Remedy, making the product a household name and forever changing the marketing and product placement paradigm for homeopathic drugs in the United States.
Dr. Hensley and his team plan to use the same methodologies to revolutionize the treatment of several other common ailments and other chronic diseases.